Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
doi: 10.1101/cshperspect.a026831 74 PaskovaLSmesny TrtkovaKFialovaBBenedikovaALangovaKKolarZ
Nat Cell Biol 2022;24:13547
2019 [doi: 10.1007/s00018-019-03263-6][Epub]
In studies by Gonzalez-Ochoa et al., when compared to a placebo, Sulodexide has been found to possibly reduce the risk of hospitalization and the need for oxygen supply while improving laboratory parameters without increasing the risk of bleeding in early high-risk COVID-19 patients (Gonzalez-Ochoa et al., 2021)
Bensky MJ, Ayalon-Dangur I, Ayalon-Dangur R et al (2019) comparison of sublingual vs
US$ 26.58
US$ 20.73
US$ 20.78
US$ 24.76
US$ 22.39
US$ 24.83
US$ 23.03
US$ 24.19
